Beypinar, I. Et Al. 2024. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study. BREAST CANCER RESEARCH AND TREATMENT , vol.208, no.3 , 597-604.

Beypinar, I., Demir, H., YASLIKAYA, Ş., Koeseci, T., Demir, B., Colak, G., ... Agaoglu, A. B.(2024). Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study. BREAST CANCER RESEARCH AND TREATMENT , vol.208, no.3, 597-604.

Beypinar, Ismail Et Al. "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study," BREAST CANCER RESEARCH AND TREATMENT , vol.208, no.3, 597-604, 2024

Beypinar, Ismail Et Al. "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study." BREAST CANCER RESEARCH AND TREATMENT , vol.208, no.3, pp.597-604, 2024

Beypinar, I. Et Al. (2024) . "Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study." BREAST CANCER RESEARCH AND TREATMENT , vol.208, no.3, pp.597-604.

@article{article, author={Ismail Beypinar Et Al. }, title={Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2024, pages={597-604} }